Chemo-linked factors may impact weight in breast cancer

Share this article:
Chemo-Linked Factors May Impact Weight in Breast Cancer
Chemo-Linked Factors May Impact Weight in Breast Cancer

(HealthDay News) -- Adjuvant chemotherapy for early-stage breast cancer can induce weight gain and a variety of metabolic changes that may be associated with a poor prognosis for some patients, according to research published in the April issue of Obesity Reviews.

Emilie Gadéa, of the Centre Jean Perrin in Clermont-Ferrand, France, and colleagues conducted a literature review to investigate causes and mechanisms associated with body weight change during chemotherapy and its association with prognosis in early-stage breast cancer.

The investigators found that some studies in recent decades attributed weight gain or loss to energy imbalance through different chemotherapy-linked factors, including poor tolerance to treatment, reductions in muscle mass and function, and hormonal alterations. The resultant modifications of body composition were in favor of loss of lean body mass and/or fat gain. An increase in adipose tissue, particularly in the abdominal region, appeared to induce insulin resistance and other metabolic disturbances through various pathways involving adipokines.

"Further investigations are required to elucidate mechanisms involved in poor prognosis of weight changes and to discover early predictive markers to identify women at high risk of weight changes. Understanding such mechanisms is key to developing personalized preventive strategies for improving the prognosis of early-stage breast cancer patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Home

Added corticosteroid not effective for cancer pain

Added corticosteroid not effective for cancer pain

In advanced cancer patients receiving opioids, methylprednisolone does not add to analgesic effect.

New care guidelines issued for prostate cancer survivors

New care guidelines issued for prostate cancer survivors

New guidelines have been developed for clinical follow-up care for prostate cancer survivors. Issues addressed include health promotion, surveillance for recurrence, and new primaries.

ASCO: Goserelin helps preserve ovarian function in early breast cancer

ASCO: Goserelin helps preserve ovarian function in early ...

For premenopausal women with hormone receptor-negative early breast cancer treated with chemotherapy, goserelin can preserve ovarian function, according to a study presented at the annual ASCO meeting.